Intact Therapeutics is Drug Delivery in United States that focus on product offerings business. Founded in 2015. They cover business area such as developer, smart gel, gastrointestinal (GI) disorder, room temperature, body temperature, ulcerative colitis, a gel technology, significantly localized concentration, drug, minimize, systemic exposure, retention, efficacy, comfort, patient, inflammatory bowel illness, access.
2015
( 9 years old in 2024 )
Product Offerings
-
640 Masonic Way
Suite 5204
Belmont, CA 94002
United States
Private
developersmart gelgastrointestinal (GI) disorderroom temperaturebody temperatureulcerative colitisa gel technologysignificantly localized concentrationdrugminimizesystemic exposureretentionefficacycomfortpatientinflammatory bowel illnessaccess
* We use standard office opening hours in near Intact Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Intact Therapeutics is Drug Delivery business from United States that founded in 2015 (9 years old in 2024), Intact Therapeutics business is focusing on Product Offerings.
Intact Therapeutics headquarter office and corporate office address is located in 640 Masonic Way Suite 5204 Belmont, CA 94002 United States.
Intact Therapeutics was founded in United States.
In 2024, Intact Therapeutics is currently focus on product offerings sector.
Above is snippet of Google Trends for "product offerings" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Intact Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.